Delphi Technologies (NYSE:DLPH) and Curaegis Technologies (OTCMKTS:CRGS) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.
This table compares Delphi Technologies and Curaegis Technologies’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Delphi Technologies pays an annual dividend of $0.34 per share and has a dividend yield of 2.0%. Curaegis Technologies does not pay a dividend. Delphi Technologies pays out 7.8% of its earnings in the form of a dividend.
This is a summary of current ratings and target prices for Delphi Technologies and Curaegis Technologies, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Delphi Technologies presently has a consensus price target of $29.15, indicating a potential upside of 70.98%. Given Delphi Technologies’ higher probable upside, equities research analysts plainly believe Delphi Technologies is more favorable than Curaegis Technologies.
Insider and Institutional Ownership
78.9% of Delphi Technologies shares are owned by institutional investors. Comparatively, 0.1% of Curaegis Technologies shares are owned by institutional investors. 0.2% of Delphi Technologies shares are owned by company insiders. Comparatively, 40.0% of Curaegis Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Delphi Technologies and Curaegis Technologies’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Delphi Technologies||$4.86 billion||0.31||$358.00 million||$4.38||3.89|
|Curaegis Technologies||$40,000.00||185.22||-$6.31 million||N/A||N/A|
Delphi Technologies has higher revenue and earnings than Curaegis Technologies.
Risk & Volatility
Delphi Technologies has a beta of 2.31, indicating that its share price is 131% more volatile than the S&P 500. Comparatively, Curaegis Technologies has a beta of -0.78, indicating that its share price is 178% less volatile than the S&P 500.
Delphi Technologies beats Curaegis Technologies on 10 of the 13 factors compared between the two stocks.
Delphi Technologies Company Profile
Delphi Technologies PLC engages in the design, development, and manufacture of integrated powertrain technologies worldwide. The company operates through two segments, Powertrain Systems and Delphi Technologies Aftermarket. The Powertrain Systems segment provides fuel injection systems, as well as other powertrain products comprising valvetrain, fuel delivery modules, ignition coils, canisters, sensors, valves, and actuators; and electronic control modules with the corresponding software, algorithms, and calibration that provide centralized management of various powertrain components. It also provides power electronics solutions, including supervisory controllers and software, and DC/DC converters and inverters. This segment sells its portfolio of technologies and solutions for propulsion systems to original equipment manufacturers of light vehicles, including passenger cars, trucks, vans, and sport-utility vehicles; and commercial vehicles, such as light-duty, medium-duty, and heavy-duty trucks, as well as commercial vans, buses, and off-highway vehicles. The Delphi Technologies Aftermarket segment manufactures and sells aftermarket products, such as cover fuel injection, electronics and engine management, maintenance and test equipment, and vehicle diagnostics to independent aftermarket and original equipment service customers, and independent retailers and wholesale distributors. Delphi Technologies PLC has a collaboration agreement with TomTom N.V. for intelligent driving controls. The company is based in London, the United Kingdom.
Curaegis Technologies Company Profile
CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of safety, wellness and power. It operates through the following segments: CURA and AegisThe CURA segment involves in advanced fatigue management products including wearable devices offering real-time alertness monitoring, and latest in online sleep or fatigue management and interactive learning. The Aegis segment develops advanced hydraulic pump and motor designs that provide higher power density, smaller size, and greater efficiency. The company was founded by Vernon E. Gleasman, James Y. Gleasman, and Keith E. Gleasman on September 25, 1996 and is headquartered in Rochester, NY.
Receive News & Ratings for Delphi Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delphi Technologies and related companies with MarketBeat.com's FREE daily email newsletter.